Details of the Drug Reposition

General Information of This Drug (ID: DME7N7O)

• Drug Name: Tissue repair stem cell therapy (DME7N7O)

Information on Drug Reposition of This Drug

2 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Dilated cardiomyopathy	DISX608J	BC43.0	Phase 1/2	[1]
Peripheral ischemia	DIS6RZFP	BD30-BD40	Phase 1/2	[1]

References

• [1] Aastrom Announces First Patient Treatment With Autologous Stem Cell Therapy for Heart Failure